Skip to content
10-Q

Quarterly Report

AMERICAN GENE ENGINEER CORP

0001214659-18-004519

← back to feed
Filed
Jun 18, 2018 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2018 · Jun 11, 2018 100M sh
Operating Cash Flow Q2 2018 · Apr 30, 2018 −$53.04K
Operating Cash Flow Q2 2018 · Apr 30, 2017 −$303.72K
Cash And Equivalents Q2 2018 · Apr 30, 2018 $1.58K
Cash And Equivalents Q2 2018 · Oct 31, 2017 $447
Cash And Equivalents Q2 2018 · Apr 30, 2017 $8.32K
Cash And Equivalents Q2 2018 · Oct 31, 2016 $308.54K
Stockholders Equity Q2 2018 · Apr 30, 2018 −$523.6K
Stockholders Equity Q2 2018 · Oct 31, 2017 −$514.72K
Current Liabilities Q2 2018 · Apr 30, 2018 $607.19K
Current Liabilities Q2 2018 · Oct 31, 2017 $599.29K
Current Assets Q2 2018 · Apr 30, 2018 $79.79K
Current Assets Q2 2018 · Oct 31, 2017 $80.78K
Total Assets Q2 2018 · Apr 30, 2018 $83.59K
Total Assets Q2 2018 · Oct 31, 2017 $84.58K
Sga Expense Q2 2018 · Apr 30, 2018 $36.61K
Sga Expense Q2 2018 · Apr 30, 2018 $63.06K
Sga Expense Q2 2018 · Apr 30, 2017 $93.89K
Sga Expense Q2 2018 · Apr 30, 2017 $178K
Net Income Q2 2018 · Apr 30, 2018 −$36.61K
Net Income Q2 2018 · Apr 30, 2018 −$63.06K
Net Income Q2 2018 · Apr 30, 2017 −$93.89K
Net Income Q2 2018 · Apr 30, 2017 −$178K